Generation Bio Total Assets 2020-2023 | GBIO

Generation Bio total assets from 2020 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Generation Bio Annual Total Assets
(Millions of US $)
2023 $375
2022 $376
2021 $477
2020 $294
2019 $42
Generation Bio Quarterly Total Assets
(Millions of US $)
2023-12-31 $375
2023-09-30 $381
2023-06-30 $405
2023-03-31 $431
2022-12-31 $376
2022-09-30 $403
2022-06-30 $419
2022-03-31 $444
2021-12-31 $477
2021-09-30 $464
2021-06-30 $491
2021-03-31 $514
2020-12-31 $294
2020-09-30 $311
2020-06-30 $331
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.193B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.482B 5.59
Dr Reddy's Laboratories (RDY) India $12.441B 19.67
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.375B 0.00
Bausch Health Cos (BHC) Canada $3.183B 2.48
Amphastar Pharmaceuticals (AMPH) United States $2.009B 13.75
Supernus Pharmaceuticals (SUPN) United States $1.646B 0.00
Taysha Gene Therapies (TSHA) United States $0.447B 0.00
Assembly Biosciences (ASMB) United States $0.069B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00